Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Cardio-onco collab may enhance safety of nivolumab anticancer therapy

14 May 2025

The safety of nivolumab anticancer therapy may be improved through close collaboration between cardiology and oncology specialists, which can help detect cardiac complications early and manage these conditions effectively, suggests a study.

Cardio-onco collab may enhance safety of nivolumab anticancer therapy

14 May 2025

Age not a factor in safety, effectiveness of pulse‐field ablation for AF

14 May 2025

Pulsed-field ablation for atrial fibrillation (AF) appears to be equally safe and effective in older patients as it is in their younger counterparts, according to a study.

Age not a factor in safety, effectiveness of pulse‐field ablation for AF

14 May 2025

Fluid restriction good for chronic HF: Aye or nay?

14 May 2025 bởi

Allowing patients with chronic heart failure (HF) to drink as much fluid as they need appears to present no additional risks, including for hospitalization and death, as shown in the FRESH-UP study presented at ACC.25. This finding challenges the current US and EU recommendations to limit daily fluid intake to 1.5 L for this population.

Fluid restriction good for chronic HF: Aye or nay?

14 May 2025

Intensive BP-lowering therapy safe for patients with acute ICH

13 May 2025

Reducing systolic blood pressure (SBP) to a target of less than 140 mm Hg does not appear to have any negative effects on diffusion-weighted imaging lesion frequency and volume in patients with acute intracerebral haemorrhage (ICH), as shown in ICHADAPT-2*.

Intensive BP-lowering therapy safe for patients with acute ICH

13 May 2025

Long-term use of antidepressants linked to sudden cardiac death

13 May 2025 bởi

New research presented at EHRA 2025 has shown that patients who have taken antidepressants for extended periods are at increased risk of sudden cardiac death.

Long-term use of antidepressants linked to sudden cardiac death

13 May 2025

Minimally invasive ECC curbs post-cardiac surgery SAEs

10 May 2025 bởi

Extracorporeal circulation, a technique for providing cardiopulmonary support during cardiac surgery, has a reduced risk of postoperative SAEs when delivered via a minimally invasive system rather than conventional technologies, according to results of the COMICS trial

Minimally invasive ECC curbs post-cardiac surgery SAEs

10 May 2025

IBD patients who undergo coronary intervention at increased risk of MACE

08 May 2025

Patients with inflammatory bowel disease (IBD) have a higher likelihood of experiencing major adverse cardiovascular events (MACE) after coronary interventions, according to a study.

IBD patients who undergo coronary intervention at increased risk of MACE

08 May 2025

Therapeutic thoracentesis of no help in patients with acute heart failure, pleural effusion

04 May 2025

A strategy of upfront routine thoracentesis in addition to standard medical therapy does not appear to improve survival outcomes for patients with acute heart failure and pleural effusion, as shown in the results of TAP-IT*.

Therapeutic thoracentesis of no help in patients with acute heart failure, pleural effusion

04 May 2025

Primary stroke mechanism identification helps predict recurrent stroke risk

02 May 2025 bởi

In medically treated symptomatic intracranial atherosclerotic stenosis (sICAS) patients, considering artery-to-artery embolism (AAE) rather than hypoperfusion as the stroke mechanism for cortical borderzone (CBZ) infarcts could better predict early recurrent stroke in the same territory (SIT), a study by the Chinese University of Hong Kong (CUHK) has found.

Primary stroke mechanism identification helps predict recurrent stroke risk

02 May 2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

02 May 2025

New drug applications approved by US FDA as of 1-15 April 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

02 May 2025

Tin tức & Cập nhật

Xem bài viết Tim mạch

Xem

Chuyên ngành:

Cardio-onco collab may enhance safety of nivolumab anticancer therapy

Cardio-onco collab may enhance safety of nivolumab anticancer therapy

Age not a factor in safety, effectiveness of pulse‐field ablation for AF

Age not a factor in safety, effectiveness of pulse‐field ablation for AF

Fluid restriction good for chronic HF: Aye or nay?

Fluid restriction good for chronic HF: Aye or nay?

Intensive BP-lowering therapy safe for patients with acute ICH

Intensive BP-lowering therapy safe for patients with acute ICH

Long-term use of antidepressants linked to sudden cardiac death

Long-term use of antidepressants linked to sudden cardiac death

Minimally invasive ECC curbs post-cardiac surgery SAEs

Minimally invasive ECC curbs post-cardiac surgery SAEs

IBD patients who undergo coronary intervention at increased risk of MACE

IBD patients who undergo coronary intervention at increased risk of MACE

Therapeutic thoracentesis of no help in patients with acute heart failure, pleural effusion

Therapeutic thoracentesis of no help in patients with acute heart failure, pleural effusion

Primary stroke mechanism identification helps predict recurrent stroke risk

Primary stroke mechanism identification helps predict recurrent stroke risk

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025